I just got back from our vacation and noticed this thread and think there is a very important point about
1st, the 4.1 month extension seen in the trial is the MEDIAN not the absolute. John points out that there could be a benefit to use the protocol and I believe that we will eventually see thatt. However the median is the number where half are located above and below that number for patients that failed all other forms of conventional treatment ~ HT, 2nd line HT, chemotherapy, etc. For many in this protocol, they are still alive today years after therapy. What Provenge carries is hope. And as they work to increase it's effectiveness there is yet even more hope.
Taxotere, generically called docetaxel, carried a life extension of 19 months for HRPC patients when it was in trial. Then it's sister came out earlier this year ~ Cabazetaxel offering yet 4 additional months at the median. But it is important to note that many have lived much longer on Taxotere, Cabazetaxel, and Provenge.
For 93k you are buying the opportunity to live far longer than the study median.
Advanced Prostate Cancer at age 44 (I am 48 now)
pT3b,N0,Mx (original PSA was 19.8) EPE, PM, SVI. Gleason 4+3=7
RALP ~ 2/17/2007 at the City of Hope near Los Angeles.
Adjuvant Radiation Therapy ~ IMRT Completed 8/07
Adjuvant Hormone Therapy ~ 28 months on Casodex and Lupron.
"I beat up this disease and took its lunch money! I am in remission."
I am currently not being treated, but I do have regular oncology visits.
I am the president of an UsTOO chapter in Las Vegas
Blog : www.caringbridge.org/visit/tonycrispino